Biredirectional Asymmetric Allylboration
J . Org. Chem., Vol. 65, No. 2, 2000 379
NH3) m/z 276 (M + NH4)+, 259 (M + H)+; HRMS (CI, NH3)
calcd for C15H31O3 (M + H)+ 259.2273, found (M + H)+
259.2279.
C28H40NO6 (M + NH4)+ 486.2856, found (M + NH4)+ 486.2846.
Anal. Calcd for C28H36O6: C, 71.77; H, 7.74. Found: C, 71.85;
H, 7.73.
(1R,5R)-6-Met h yl-1-p h en yl-3-m et h ylen eh ep t a n e-1,5-
d iol (9): as a 3:5 mixture with 1b; TLC Rf 0.33 (2:3 EtOAc/
hexanes); 1H NMR (300 MHz, CDCl3) 7.40-7.28 (m, 5H), 5.12
(s, 1H), 5.09 (s, 1H), 5.04 (s, 3.33H), 4.89-4.80 (m, 1H), 3.59-
3.48 (m, 4.33H), 2.58-2.40 (m, 2H), 2.35-2.31 (m, 4.33H),
2.10-2.03 (m, 4.33H), 1.75-1.67 (m, 4.33H), 0.99-0.97 (m,
26H).
(4S,6R)-4-[(2-ter t-Bu t yloxy)ca r b on yloxy)-(2R)-p h en -
eth yl]-4-iod om eth yl-6-p h en yl-1,3-d ioxa n -2-on e (14). IBr
(1.0 M in CH2Cl2, 0.3 mL, 0.3 mmol) was slowly added to a
solution of dicarbonate 13 (100 mg, 0.21 mmol) in PhMe (5
mL) at -80 to -85 °C (CO2-Et2O bath), and the mixture was
stirred at this temperature for 4 h. A mixture of aqueous
NaHCO3 and Na2S2O3 was added, the solution was allowed to
warm to room temperature and extracted with Et2O. The
combined organic phase was washed with H2O, dried, evapo-
rated under reduced pressure, and chromatographed (1:9 Et2O/
pentane) to furnish iodolactone 14 as an off-white foam (93
(6R)-4-(2-H yd r oxy-2R-p h en ylet h yl)-4-iod om et h yl-6-
p h en yl-1,3-d ioxa n -2-on e (11). n-BuLi (2.4 M in hexanes, 0.5
mL, 1.2 mmol) was added to a solution of (1R,5R)-1a (140 mg,
0.52 mmol) in THF (10 mL), and after 1 h at room temperature
CO2 was bubbled through the solution for 1 min, a solution of
I2 (400 mg, 1.57 mmol) in THF (5 mL) was added, and the
mixture was stirred for 18 h at room temperature. The solution
was poured into water and extracted with Et2O. The combined
organic phase was washed with water, dried (MgSO4), con-
centrated under reduced pressure, and chromatographed (1:4
EtOAc/hexanes) to give 11 as a clear oil (138 mg, 61% as a 1:1
mixture of diastereoisomers): TLC Rf 0.4 (2:3 EtOAc/hexanes);
mg, 82%): TLC Rf 0.25 (1:4 EtOAc/hexanes); [R]23 +0.75° (c
D
6.7, CHCl3); IR (CHCl3) 3033, 2978, 2930, 2856, 1746 cm-1
;
1H NMR (300 MHz, CDCl3) δ 7.45-7.35 (m, 10H), 5.43 (dd,
1H, J ) 11.9, 2.9 Hz), 5.43 (dd, 1H, J ) 11.9, 2.9 Hz), 3.50 (d,
1H, J ) 10.9 Hz), 3.42 (d, 1H, J ) 10.9 Hz), 2.78 (dd, 1H J )
15.2, 8.6 Hz), 2.49 (m, 2H), 2.24 (dd, 1H, J ) 14.5, 12.2 Hz),
1.47 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 152.4, 148.3, 139.8,
137.0, 129.1, 129.0, 128.7, 126.2, 125.7, 83.2, 81.3, 76.7, 74.2,
44.1, 39.7, 27.7, 13.8; MS (CI, NH3) m/z 556 (M + NH4)+;
HRMS (CI, NH3) calcd for C24H31INO6 (M + NH4)+ 556.1196,
found (M + NH4)+ 556.1216. Anal. Calcd for C24H27IO6: C,
53.54; H, 5.06. Found: C, 53.60; H, 4.88.
1
IR (film) 3442, 3062, 3031, 2956, 2927, 2871, 1739 cm-1; H
NMR (300 MHz, CDCl3) δ 7.45-7.35 (m, 10H), 5.65-5.45 (m,
1H), 5.16-5.06 (m, 1H), 4.10-3.45 (m, 3H), 2.87-2.10 (m, 4H);
MS (CI, NH3) m/z 471 (M + H - H2O)+, 453 (M + H - 2H2O)+.
(1R,5R)-(+)-5-(ter t-Bu tyldim eth ylsily)oxy-1,5-diph en yl-
3-m eth ylen e-1-p en ta n ol (12). A solution of iodocarbonate 11
(99 mg, 0.23 mmol), imidazole (25 mg, 0.37 mmol), and tert-
butyldimethylsilyl chloride (50 mg, 0.33 mmol) in DMF (1 mL)
was stirred at room temperature for 18 h. H2O was added (10
mL) and the solution extracted with Et2O. The ethereal
extracts were washed with dilute HCl, water, and brine, dried
(MgSO4), evaporated, and chromatographed to yield the in-
termediate silyl carbonate. This was dissolved directly in
glacial AcOH (3 mL) and stirred vigorously while zinc dust
was added (50 mg, 0.76 mmol). After 0.5 h saturated aqueous
NaHCO3 was added until effervescence ceased, and the
mixture extracted with Et2O. The combined extracts were
washed with H2O, dried, concentrated, and chromatographed
on silica gel (1:19 EtOAc/hexanes) to give alcohol 12 (35 mg,
40%): TLC Rf 0.43 (1:4 EtOAc/hexanes); [R]23D +48.1° (c 1.65,
CHCl3); IR (CHCl3) 3422, 3065, 3029, 2953, 2929, 2887, 2857,
1643 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.38-7.30 (m, 10H),
5.02 (s, 1H), 5.00 (s, 1H), 4.81-4.78 (m, 2H), 2.60-2.40 (m,
4H), 2.25 (br s, 1H), 0.89 (s, 9H), 0.03 (s, 3H), -0.15 (s, 3H);
13C NMR (75 MHz, CDCl3) δ 145.1, 144.1, 142.7, 128.4, 128.1,
127.5, 127.2, 126.0, 125.8, 116.7, 74.5, 71.5, 47.1, 47.0, 25.9,
18.3, -4.6, -4.9 (also present from the minor diastereoisomer
143.2, 116.2, 47.5); MS (CI, NH3) m/z 383 (M + H)+; HRMS
(CI, NH3) calcd for C24H35O2Si (M + H)+ 383.2403, found (M
+ NH4)+ 383.2403. Anal. Calcd for C24H35O2Si: C, 75.34; H,
8.96. Found: C, 75.20; H, 8.82.
(1R ,5R )-(+)-1,5-Di[(t er t -b u t yloxy)ca r b on yloxy]-1,5-
d ip h en yl-3-m eth ylen ep en ta n e (13). To a solution of 1a (350
mg, 1.31 mmol) in THF (3.5 mL) at 0 °C was added dropwise
a solution of n-BuLi (2.4 M in hexanes, 1.5 mL, 3.6 mmol),
and the mixture was stirred for 30 min. A solution of 2-(tert-
butoxycarbonylimino)-2-phenylacetonitrile (BOC-ON) (890
mg, 3.6 mmol) in THF (5 mL) was added, and the mixture
was warmed to room temperature and stirred for 18 h. The
solution was poured into aqueous NaOH (0.4M, 30 mL) and
extracted with Et2O. The ether layer was washed with brine,
and the aqueous phase was back-extracted with Et2O. The
combined organic phase was dried (MgSO4), concentrated
under reduced pressure, and chromatographed (1:19 EtOAc/
hexanes), furnishing dicarbonate 13 as an off-white solid (460
(3R,7R)-1,9-Di[(t et r a h yd r op yr a n -2-yl)oxy]-5-m et h yl-
en en on a n e-3,7-d iol (16). Following the general procedure for
double asymmetric allylboration using (S,S)-3 and 1514 gave
16 as a colorless oil (45% as an inseparable mixture of
diastereoisomers (ratio not determined)): TLC Rf 0.08 (2:3
EtOAc/hexanes); IR (film) 3428, 3073, 2940, 2872, 1643 cm-1
;
1H NMR (300 MHz, CDCl3) δ 4.97 (s, 2H), 4.59 (m, 2H), 4.00-
3.80 (m, 6H), 3.65-3.43 (m, 4H), 3.32 (br s, 2H), 2.30-2.15
(m, 4H), 1.85-1.50 (m, 16H); 13C NMR (75 MHz, CDCl3) δ
143.7, 115.2, 99.1, 99.0, 68.9, 68.8, 68.5, 68.5, 65.9, 65.8, 62.6,
62.3, 44.1, 36.4, 30.7, 30.5, 25.3, 19.6, 19.5; MS (CI, NH3) m/z
388 (M + NH4)+, 373 (M + H)+; HRMS (CI, NH3) calcd for
C20H37O6 (M + H)+ 373.2590, found (M + H)+ 373.2592. Anal.
Calcd for C20H36O6: C, 64.49; H, 9.74. Found: C, 64.68; H,
9.89.
(3S,7S)-3,7-Dih yd r oxy-1,9-d i[(t et r a h yd r op yr a n -2-yl)-
oxy]n on a n -5-on e (17). From 16 (300 mg, 0.81 mmol) the
procedure described for 7 gave 17 as a colorless oil (295 mg,
97%): TLC Rf 0.32 (1:24 MeOH/CHCl3); IR (film) 3427, 3008,
2944, 2875, 1708 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.48 (br
s, 2H), 4.23-4.15 (m, 2H), 3.87-3.71 (m, 4H), 3.53-3.41 (m,
6H), 2.63-2.47 (m, 4H), 1.76-1.42 (m, 16H); 1H NMR (300
MHz, CD3OD) δ 4.61 (br s, 2H), 4.25 (m, 2H), 3.92-3.84 (m,
4H), 3.48-3.58 (m, 4H), 3.33 (m, 2H), 2.66 (s, 4H), 1.86-1.54
(m, 16H); 13C NMR (75 MHz, CDCl3) δ 210.8, 210.7, 210.7,
99.0, 99.0, 66.3, 66.1, 64.9, 64.8, 62.5, 62.3, 50.5, 36.2, 30.6,
30.5, 25.3, 19.6, 19.5; MS (CI, NH3) m/z 392 (M + NH4)+;
HRMS (CI, NH3) calcd for C19H38NO7 (M + NH4)+ 392.2648,
found (M + NH4)+ 392.2654. Anal. Calcd for C19H34O7: C,
60.94; H, 9.15. Found: C, 61.00; H, 9.26.
(4S,6S,10S)-(+)-1,7-Dioxa sp ir o[5.5]u n d eca n -4,10-d iol
(18).13 A solution of ketone 17 (795 mg, 2.13 mmol) in MeOH
(10 mL) was stirred at room temperature with freshly washed
DOWEX 50WX8-400 resin (50 mg) for 18 h. The mixture was
filtered, and the resin was washed with further MeOH. The
combined organic phase was concentrated to give a solid
residue. Chromatography (1:19 MeOH/CHCl3) gave first an
unidentified mixture of products, followed by spiroketal 18 as
a white solid (300 mg, 75%): mp 119-120 °C (Me2CO) (lit.13
mp 153-154 °C); TLC Rf 0.07 (1:19 MeOH/CHCl3); [R]23
D
+124.5° (c 0.4, Me2CO) (lit.13 [R]D +121.4° (c 0.5, Me2CO)); IR
mg, 75%): mp 79-80 °C; TLC Rf 0.46 (1:4 EtOAc/hexanes);
(CHCl3) 3376, 2951, 2879 cm-1 1H NMR (300 MHz, (CD3)2-
;
1
[R]23 +35.7° (c 0.8, CHCl3); IR (CHCl3) 2987, 1738 cm-1; H
D
CO) δ 4.00-3.90 (m, 2H), 3.74 (m, 2H), 3.63-3.53 (m, 4H),
1.98-1.91 (m, 2H), 1.85-1.77 (m, 2H), 1.45-1.22 (m, 4H); 1H
NMR (300 MHz, CD3OD) δ 4.03-3.92 (m, 2H), 3.69-3.55 (m,
6H), 2.02-1.95 (m, 2H), 1.88-1.82 (m, 2H), 1.51-1.27 (m, 4H);
13C NMR (75 MHz, (CD3)2CO) δ 99.0, 63.2, 58.5, 45.3, 35.2;
NMR (300 MHz, CDCl3) δ 7.35-7.30 (m, 10H), 5.72-5.62 (m,
2H), 4.91 (s, 2H), 2.65-2.40 (m, 4H), 1.45 (s, 18H); 13C NMR
(75 MHz, CDCl3) δ 152.9, 140.1, 132.9, 128.5, 128.0, 126.4,
117.1, 82.1, 65.9, 43.2, 27.8 (also present from the minor
diastereoisomer 129.3, 127.5, 27.7); HRMS (CI, NH3) calcd for